Danielle C Ompad1, Jiayu Wang2, Konstantin Dumchev3, Julia Barska4, Maria Samko5, Oleksandr Zeziulin3, Tetiana Saliuk5, Olga Varetska5, Jack DeHovitz6. 1. New York University College of Global Public Health, New York, NY, USA; Center for Drug Use and HIV Research, New York University, New York, NY, USA; Center for Health, Identity, Behavior, and Prevention Studies, New York University, New York, NY, USA. Electronic address: dco2@nyu.edu. 2. Center for Health, Identity, Behavior, and Prevention Studies, New York University, New York, NY, USA. 3. Ukrainian Institute on Public Health Policy, Kiev, Ukraine. 4. National University of Kyiv-Mohyla Academy, Kiev, Ukraine. 5. Alliance for Public Health (Formerly ICF International HIV/AIDS Alliance in Ukraine), Kiev, Ukraine. 6. SUNY Downstate Medical Center, Department of Medicine, Brooklyn, NY, USA.
Abstract
BACKGROUND: Program utilization patterns are described within a large network of harm reduction service providers in Ukraine. The relationship between utilization patterns and HIV incidence is determined among people who inject drugs (PWID) controlling for oblast-level HIV incidence and treatment/syringe coverage. METHODS: Data were extracted from the network's monitoring and evaluation database (January 2011-September 2014, n=327,758 clients). Latent profile analysis was used to determine harm reduction utilization patterns using the number of HIV tests received annually and the number of condoms, syringes, and services (i.e., information and counseling sessions) received monthly over a year. Cox proportional hazards regression determined the relations between HIV seroconversion and utilization class membership. RESULTS: In the final 4-class model, class 1 (34.0% of clients) received 0.1 HIV tests, 1.3 syringes, 0.6 condom and minimal counseling and information sessions per month; class 2 (33.6%) received 8.6 syringes, 3.2 condoms, and 0.5 HIV tests and counseling and information sessions; class 3 (19.1%) received 1 HIV test, 11.9 syringes, 4.3 condoms, and 0.7 information and counseling sessions; class 4 (13.3%) received 1 HIV test, 26.1 syringes, 10.3 condoms, and 1.8 information and 1.9 counseling sessions. Class 4 clients had significantly decreased risk for HIV seroconversion as compared to those in class 1 after controlling for oblast-level characteristics. CONCLUSION: Injection drug use continues to be a major mode of HIV transmission in Ukraine, making evaluation of harm reduction efforts in reducing HIV incidence among PWID critical. These analyses suggest that receiving more syringes and condoms decreased risk of HIV. Scaling up HIV testing and harm reduction services is warranted.
BACKGROUND: Program utilization patterns are described within a large network of harm reduction service providers in Ukraine. The relationship between utilization patterns and HIV incidence is determined among people who inject drugs (PWID) controlling for oblast-level HIV incidence and treatment/syringe coverage. METHODS: Data were extracted from the network's monitoring and evaluation database (January 2011-September 2014, n=327,758 clients). Latent profile analysis was used to determine harm reduction utilization patterns using the number of HIV tests received annually and the number of condoms, syringes, and services (i.e., information and counseling sessions) received monthly over a year. Cox proportional hazards regression determined the relations between HIV seroconversion and utilization class membership. RESULTS: In the final 4-class model, class 1 (34.0% of clients) received 0.1 HIV tests, 1.3 syringes, 0.6 condom and minimal counseling and information sessions per month; class 2 (33.6%) received 8.6 syringes, 3.2 condoms, and 0.5 HIV tests and counseling and information sessions; class 3 (19.1%) received 1 HIV test, 11.9 syringes, 4.3 condoms, and 0.7 information and counseling sessions; class 4 (13.3%) received 1 HIV test, 26.1 syringes, 10.3 condoms, and 1.8 information and 1.9 counseling sessions. Class 4 clients had significantly decreased risk for HIV seroconversion as compared to those in class 1 after controlling for oblast-level characteristics. CONCLUSION: Injection drug use continues to be a major mode of HIV transmission in Ukraine, making evaluation of harm reduction efforts in reducing HIV incidence among PWID critical. These analyses suggest that receiving more syringes and condoms decreased risk of HIV. Scaling up HIV testing and harm reduction services is warranted.
Authors: Louisa Degenhardt; Bradley M Mathers; Andrea L Wirtz; Daniel Wolfe; Adeeba Kamarulzaman; M Patrizia Carrieri; Steffanie A Strathdee; Kasia Malinowska-Sempruch; Michel Kazatchkine; Chris Beyrer Journal: Int J Drug Policy Date: 2013-09-04
Authors: Sergii Dvoriak; Andrey Karachevsky; Sumedha Chhatre; Robert Booth; David Metzger; Joseph Schumacher; Nina Chychula; Anna Pecoraro; George Woody Journal: Drug Alcohol Depend Date: 2014-01-30 Impact factor: 4.492
Authors: Alyona Mazhnaya; Tatiana I Andreeva; Steve Samuels; Jack DeHovitz; Tetyana Salyuk; Louise-Anne McNutt Journal: J Int AIDS Soc Date: 2014-02-17 Impact factor: 5.396
Authors: Charles R Vitek; Jurja-Ivana Čakalo; Yuri V Kruglov; Konstantin V Dumchev; Tetyana O Salyuk; Ivana Božičević; Andrew L Baughman; Hilary H Spindler; Violetta A Martsynovska; Yuri V Kobyshcha; Abu S Abdul-Quader; George W Rutherford Journal: PLoS One Date: 2014-09-24 Impact factor: 3.240
Authors: Olga Morozova; Robert E Booth; Sergii Dvoriak; Kostyantyn Dumchev; Yana Sazonova; Tetiana Saliuk; Forrest W Crawford Journal: Int J Drug Policy Date: 2019-08-10
Authors: Kathryn E Lancaster; Katie R Mollan; Brett S Hanscom; Bonnie E Shook-Sa; Tran V Ha; Kostyantyn Dumchev; Zubairi Djoerban; Scott M Rose; Carl A Latkin; David S Metzger; Vivian F Go; Sergii Dvoriak; Sarah A Reifeis; Estelle M Piwowar-Manning; Paul Richardson; Michael G Hudgens; Erica L Hamilton; Susan H Eshleman; Hepa Susami; Viet Anh Chu; Samsuridjal Djauzi; Tetiana Kiriazova; Do Thi Nhan; David N Burns; William C Miller; Irving F Hoffman Journal: Open Forum Infect Dis Date: 2021-05-29 Impact factor: 4.423
Authors: Adam Trickey; Nadiya Semchuk; Tetiana Saliuk; Yana Sazonova; Olga Varetska; Josephine G Walker; Aaron G Lim; Jack Stone; Peter Vickerman Journal: J Int AIDS Soc Date: 2020-08 Impact factor: 5.396